Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin vs Mirabegron for OAB Symptoms After TURP
NCT03632772Phase 2Unknown
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Aug 2018
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of solifenacin, mirabegron in overactive bladder syndrome (OAB), sponsored by Buddhist Tzu Chi General Hospital. Status: unknown.
02
Drugs
solifenacinmirabegron
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT03632772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03632772.